IBA SA : IBA to Install Proton Therapy Center in Virginia, USA
05 Juillet 2017 - 7:35AM
IBA to Install
Proton Therapy Center in Virginia, USA
Contract signed
with Inova Health Care Services for two-room Proteus®PLUS* proton
therapy system near IBA's North American Headquarters
Reston, VA, USA,
July 5th, 2017 -
IBA (Ion Beam Applications S.A.), the world's leading provider of
proton therapy solutions for the treatment of cancer, and Inova
Health Care Services (Inova) today signed a contract for a two-room
Proteus®PLUS* proton
therapy solution, each treatment room equipped with Pencil Beam
Scanning capability and integrated Cone Beam CT.
The total value of the equipment
and services supplied by IBA to Inova is approximately $60M. The
project is fully financed and includes a long-term operation and
maintenance contract. Inova plans to start treating patients by
2020.
Olivier Legrain,
Chief Executive Officer of IBA SA, commented: "We are
pleased to announce that Inova has selected IBA as its
proton therapy partner. IBA's proton therapy technology has been
used to treat more cancer patients than any other
proton therapy company in the world and we look forward
to bringing this powerful cancer treatment tool to the
patient community of Northern Virginia and beyond."
Beth Klein,
President of IBA North America, added: "Inova's proton therapy
project is unique in that it is located only 15 miles from IBA's
North America Headquarters in Reston, Virginia, where we have the
largest and most comprehensive Proton therapy support structure in
the industry. Having the Inova center located near our North
American office will facilitate collaboration with them as we work
together to advance the use of proton therapy for those patients
and families impacted by this devastating disease."
"The addition of proton therapy to
our oncology services, will allow Inova to build upon our already
strong local, national and international oncology services reach by
providing one of the most significant technology innovations in the
treatment of Cancer," added Thomas Graves, Vice President for
Cancer Services and Associate Director for Administration of the
Inova Dwight and Martha Schar Cancer Institute. "The Center
will be housed at Inova's Center for Personalized Health, offering
patients easy access from anywhere in Virginia and the Metro DC
area. This advanced technology will be an excellent complement to
the best in class oncology services we will be offering at the
facility."
Dr. Gopal Bajaj,
Chairman and Medical Director of Radiation Oncology at Inova Dwight
and Martha Schar Cancer Institute, added: "Being able to
provide such a powerful cancer treatment truly puts Inova's
radiation oncology department at the forefront of cancer treatment
delivery. Proton therapy is an exciting alternative to traditional
radiation treatment protocols, allowing us to treat many cancer
patients more effectively, and often without the uncomfortable side
effects that traditional treatments may cause. This technology will
have a very positive impact on the thousands of people in our
community who are touched by cancer."
***ENDS***
About
IBA
IBA (Ion Beam Applications S.A.) is a global medical technology
company focused on bringing integrated and innovative solutions for
the diagnosis and treatment of cancer. The company is the worldwide
technology leader in the field of proton therapy, considered to be
the most advanced form of radiation therapy available today. IBA's
proton therapy solutions are flexible and adaptable, allowing
customers to choose from universal full-scale proton therapy
centers as well as compact, single room solutions. In addition, IBA
also has a radiation dosimetry business and develops particle
accelerators for the medical world and industry. Headquartered in
Belgium and employing about 1,500 people worldwide, IBA has
installed systems across the world.
IBA is listed on the Pan-European
stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg
IBAB.BB).
More information can be found at:
www.iba-worldwide.com
*Proteus®PLUS is the
brand name of a configuration of the Proteus®235
About
Inova
Inova is a global leader in personalized health, which
leverages precision medicine to predict, prevent and treat disease,
enabling individuals to live longer, healthier lives. Inova serves
more than 2 million people each year throughout the Washington, DC,
metro area and beyond.
Inova's five hospitals include more than 1,700 licensed beds and
16,000 employees. Inova encompasses the full array of health
services, including the area's only Level 1 Trauma Center and Level
IV neonatal intensive care unit. Inova is also home to nationally
and internationally recognized Inova Heart and Vascular
Institute (IHVI), Inova Translational Medicine Institute
(ITMI) focused on genomics research, Inova Neuroscience
Institute, Inova Children's Hospital and Inova Schar Cancer
Institute soon to include proton therapy.
For further
information, please contact:
IBA
Soumya Chandramouli
Chief Financial Officer
Bernard
Dandoy
Investor Relations
+32 10 475 890
Investorrelations@iba-group.com
Thomas
Ralet
Vice-President Corporate Communication
+32 10 475 890
communication@iba-group.com
For media and
investor enquiries:
Consilium
Strategic Communications
Amber Fennell, Matthew Neal, Ivar Milligan
+44 (0) 20 3709 5700
IBA@consilium-comms.com
IBA to Install Proton Therapy
Center in Virginia, USA
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: IBA SA via Globenewswire
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024